MENU
GRI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
GRI Bio (GRI) Ownership - Who owns GRI Bio?
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders... Show more
Profile
Industry
N/A
Address
2223 Avenida De La Playa
Phone
+1 619 400-1170
Employees
4
Web
https://www.gribio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.1M
P/E Ratio
0.00
Total Cash
5.03M
Projected Growth
N/A
Total Debt
119K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
6.91
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GRI
Capitalization
1.1M
P/E Ratio
0.00
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
5.03M
Total Cash/Share
6.91
Total Debt
119K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.03M
P/B Ratio
0.27
Cash Flow
N/A
Earnings
-55.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
3.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-188.78
Shares Held By Institutions
214K
Shares Outstanding - Current
727K
Total Liabilities
1.71M
Total Volume MTD
N/A
Value
1
Gain YTD
-89.278
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2223 Avenida De La Playa
Phone
+1 619 400-1170
Employees
4
Web
https://www.gribio.com